Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution for Life Sciences

Real-world clinical data provider Atropos Health recently announced a partnership with global professional services firm Guidehouse to jointly develop a clinical decision support solution that can be used to operationalize real-world evidence from within the existing workflows of clinical and life sciences teams. Through this development, medical care providers will be able to use evidence-based clinical insights to quickly inform decisions regarding patient diagnoses and treatments without leaving the point-of-care.

Atropos Health CEO and co-founder Dr. Brigham Hyde expressed his enthusiasm with the announcement, stating in the press release that "Partnering with Guidehouse marks a pivotal moment in our mission to bring real-world evidence to the forefront of clinical and commercial decision making. Together, we can deliver AI-driven insights at a scale and speed the pharmaceutical industry has never seen before-helping get the right treatments to the right patients faster, with a goal to ultimately save lives."

Jacob Graham, Partner of Life Sciences at Guidehouse also shared in Dr. Hyde's excitement about the partnership, saying "By combining Atropos Health's predictive modeling and evidence capabilities with Guidehouse's experience operationalizing solutions in the market, we are helping clients embed real-world evidence into care delivery in a way that drives measurable clinical and commercial impact."

Founded in 2019 by Saurabh Gombar, Nigam Shah, and Brigham Hyde, Atropos Health has quickly made a name for itself operating across a wide variety of clinical specialties with its Rapid Analytics, On-Demand Insights, and Evidence-Based Care offerings. For more information about this announcement, read the press release below.

See related materials:

• Atropos Health + Guidehouse press release
• Atropos Health website
• Atropos Health LinkedIn
• Guidehouse website
• Guidehouse LinkedIn